Skip to search formSkip to main contentSkip to account menu

LMP 420

Known as: LMP-420, LMP420 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
LMP-420, a Small Molecular Inhibitor of TNF-α, Prolongs Islet Allograft Survival by Induction of Suppressor of Cytokine Signaling-1: Synergistic Effect with Cyclosporin-A
Inflammatory insults following islet transplantation (ITx) hinders engraftment and long-term function of the transplanted (Tx… 
Review
2011
Review
2011
New nucleoside analogs for patients with hematological malignancies
Introduction: In the last few years, several new purine and pyrimidine nucleoside analogs have been synthesized and made… 
2010
2010
LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells
B-cell chronic lymphocytic leukemia (CLL) is characterized by slow accumulation of malignant cells, which are supported in the… 
2009
2009
The Interaction of Monocyte Chemoattractant Protein‐1 and Tumour Necrosis Factor‐α in Mycobacterium tuberculosis‐induced HIV‐1 Replication at Sites of Active Tuberculosis
Tuberculosis (TB) is a prominent opportunistic infection in HIV‐1‐infected subjects and enhances HIV‐1 replication. TB is… 
2008
2008
Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription
BackgroundLMP-420 is a boronic acid-containing purine nucleoside analogue that transcriptionally inhibits TNF production but is… 
2006
2006
LMP-420, un nouvelle approche thérapeutique pour le paludisme cérébral ?
2006
2006
LMP-420, un nouvelle approche thrapeutique pour le paludisme crbral ?
1. Wessman M, Kaunisto M, Kallela M, Palotie A. The molecular genetics of migraine. Ann Med 2004 ; 36 : 462-73. 2. Dichgans M… 
2005
2005
A Tool to Estimate the Risks of Repeat Cesarean Section
2005
2005
Targeting of Endothelial Activation in Cerebral Malaria
2005
2005
Getting More Mileage from Lymph Node Biopsies
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)